Jon Congleton - Sep 6, 2023 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Signature
/s/ Adam Levy, Attorney-in-fact
Stock symbol
MLYS
Transactions as of
Sep 6, 2023
Transactions value $
$27,180
Form type
4
Date filed
9/8/2023, 08:49 AM
Previous filing
Aug 21, 2023
Next filing
Nov 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Purchase $27.2K +2.25K +0.22% $12.08 1.04M Sep 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $11.9860 to $12.1202. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.